Table 1.

Patient demographics, vaccine history, and symptoms

Sample	Sex	Age	Height (cm)	Weight (kg)	Vaccine received	First dose	Second dose	Symptoms	Comorbidities†	N1 qPCR Ct	Day of positive test	Clinical outcome
Patient 0a	Male	67–69	177.8	81.6	Covaxin BBV152	2021-03-02	2021-03-31	Fever, cough, body aches, fatigue, loss of taste and/or smell, Shortness of breath at rest, Shortness of breath with activity	None	29	Day 4	Deceased
Patient 0b	Female	65–70	152.4	53	Covaxin BBV152	2021-03-02	2021-03-30	Fever, cough, body aches, fatigue, loss of taste and/or smell, Shortness of breath at rest, Shortness of breath with activity	Diabetes	27	Day 4	Recovered
Patient 1	Male	60–66	172	68	Pfizer BNT162b2	2021-12-30	2021-01-20	Cough, fatigue	None	17	Day 4	Recovered
Patient 2	Male	59–64	170.1	77	Pfizer BNT162b2	2021-01-07	2021-01-28	Fever, cough, fatigue	Hypertension	24	Day 5	Recovered
Patient 3	Female	51–56	155	63.5	Moderna mRNA-1273	2020-12-30	2021-01-26	Fever, cough, body aches, fatigue, loss of taste and/or smell	Overweight	25	Day 5	Recovered
Patient 4	Female	51–56	162.6	88.5	Moderna mRNA-1273	2021-01-04	2021-02-01	Fatigue, loss of taste and/or smell	Overweight	22	Day 5	Recovered

^†As defined by the Centers for Disease Control and Prevention